Literature DB >> 2965724

Characterization of a suppressor cell line which downgrades experimental autoimmune uveoretinitis in the rat.

R R Caspi1, T Kuwabara, R B Nussenblatt.   

Abstract

A Ts lymphocyte line was isolated from spleens of rats primed with the retinal soluble Ag (SAg) in the anterior chamber of the eye. This line could inhibit in vitro SAg-driven proliferation of uveitogenic Th lymphocytes, in a radioresistant, Ag-independent manner. Adoptively transferred Ts line cells were found to downgrade experimental autoimmune uveoretinitis in actively immunized syngeneic recipients. The initial surface phenotype (OX8+) of the Ts line was unstable in vitro, however, the cells expressed suppressor function irrespective of phenotype. The mechanism of suppression did not appear to involve consumption of IL-2 or direct cytolysis of uveitogenic Th lymphocytes, but rather the production of a soluble suppressor factor. These findings may suggest an in vivo role for suppressor lymphocytes, capable of inhibiting primed Th cells, in the regulation of experimental autoimmune uveoretinitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965724

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.

Authors:  E Uchio; M Kijima; M Ishioka; S Tanaka; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

2.  Experimental autoimmune uveoretinitis: idiotypic regulation and disease suppression.

Authors:  Y De Kozak; M Mirshahi
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

3.  Flare-up reaction of streptococcal cell wall induced arthritis in Lewis and F344 rats: the role of T lymphocytes.

Authors:  M F van den Broek; M C van Bruggen; S A Stimpson; A J Severijnen; L B van de Putte; W B van den Berg
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

4.  AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.

Authors:  So Jin Bing; Itay Shemesh; Wai Po Chong; Reiko Horai; Yingyos Jittayasothorn; Phyllis B Silver; Benjamin Sredni; Rachel R Caspi
Journal:  J Autoimmun       Date:  2019-03-08       Impact factor: 7.094

Review 5.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 6.  A review of the mechanisms of oral tolerance and immunotherapy.

Authors:  W Sosroseno
Journal:  J R Soc Med       Date:  1995-01       Impact factor: 5.344

7.  Generation and characterization of a continuous line of CD8+ suppressively regulatory T lymphocytes which down-regulates experimental autoimmune orchitis (EAO) in mice.

Authors:  A Mukasa; C Hiramine; K Hojo
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

Review 8.  Experimental autoimmune uveoretinitis (EAU) versus experimental allergic encephalomyelitis (EAE): a comparison of T cell-mediated mechanisms.

Authors:  V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 9.  Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.

Authors:  Ning Qu; Mingli Xu; Izuru Mizoguchi; Jun-ichi Furusawa; Kotaro Kaneko; Kazunori Watanabe; Junichiro Mizuguchi; Masahiro Itoh; Yutaka Kawakami; Takayuki Yoshimoto
Journal:  Clin Dev Immunol       Date:  2013-07-14

Review 10.  Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update.

Authors:  Elvis Hysa; Carlo Alberto Cutolo; Emanuele Gotelli; Greta Pacini; Carlotta Schenone; Elke O Kreps; Vanessa Smith; Maurizio Cutolo
Journal:  Eur J Clin Invest       Date:  2021-05-05       Impact factor: 4.686

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.